16.48
전일 마감가:
$16.91
열려 있는:
$16.74
하루 거래량:
367.45K
Relative Volume:
0.22
시가총액:
$1.65B
수익:
-
순이익/손실:
$-115.88M
주가수익비율:
-10.65
EPS:
-1.5468
순현금흐름:
$-104.72M
1주 성능:
+5.29%
1개월 성능:
+43.44%
6개월 성능:
-54.06%
1년 성능:
-15.42%
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
EWTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
EWTX
Edgewise Therapeutics Inc
|
16.49 | 1.65B | 0 | -115.88M | -104.72M | -1.5468 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.99 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.73 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
653.95 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
271.21 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-30 | 개시 | Guggenheim | Buy |
2025-04-02 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
2025-03-07 | 개시 | Scotiabank | Sector Outperform |
2025-01-22 | 개시 | Stifel | Hold |
2024-11-22 | 개시 | Evercore ISI | Outperform |
2024-03-07 | 개시 | Piper Sandler | Overweight |
2023-05-01 | 개시 | Truist | Buy |
2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
2022-01-28 | 개시 | Goldman | Neutral |
모두보기
엣지와이즈 주식(EWTX)의 최신 뉴스
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Adage Capital Partners GP L.L.C. Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Coverage Initiated at Guggenheim - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Schonfeld Strategic Advisors LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Acuta Capital Partners LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Invesco Ltd. Reduces Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
Novo Holdings A S Sells 549,900 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (EWTX) Expected to Announce Earnings on Thursday - MarketBeat
Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Voya Investment Management LLC - MarketBeat
Foresite Capital Management VI LLC Purchases New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
First Light Asset Management LLC Purchases Shares of 780,639 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Stock Popped This Week - The Globe and Mail
Edgewise Therapeutics (EWTX) Initiated at Buy by Guggenheim, Pot - GuruFocus
Edgewise a new buy at Guggenheim on two pipeline prospects - Seeking Alpha
Edgewise Therapeutics (EWTX) Receives Positive Coverage with Str - GuruFocus
Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target - marketscreener.com
79,381 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Harvest Investment Services LLC - MarketBeat
JPMorgan Chase & Co. Sells 34,071 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Russell Investments Group Ltd. Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at Wedbush - MarketBeat
Analysts Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.38 - MarketBeat
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Insider Monkey
Jump Financial LLC Sells 76,628 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Walleye Capital LLC - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 9.4%Still a Buy? - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by EAM Investors LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by New Leaf Venture Partners L.L.C. - MarketBeat
Norges Bank Acquires New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
(EWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Trexquant Investment LP Invests $2 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week LowHere's What Happened - MarketBeat
Vanguard Group Inc. Sells 49,214 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Leerink Partnrs Issues Optimistic Outlook for EWTX Earnings - MarketBeat
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엣지와이즈 주식 (EWTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
ORBIMED ADVISORS LLC | Director |
Apr 03 '25 |
Buy |
20.13 |
496,771 |
10,000,000 |
14,809,075 |
Russell Alan J | Chief Scientific Officer |
Mar 07 '25 |
Option Exercise |
0.18 |
200 |
36 |
15,063 |
Russell Alan J | Chief Scientific Officer |
Mar 07 '25 |
Sale |
30.02 |
200 |
6,004 |
14,863 |
KOCH KEVIN | President and CEO |
Mar 07 '25 |
Option Exercise |
0.18 |
100 |
18 |
14,578 |
KOCH KEVIN | President and CEO |
Mar 07 '25 |
Sale |
30.00 |
100 |
3,000 |
14,478 |
Russell Alan J | Chief Scientific Officer |
Feb 05 '25 |
Option Exercise |
0.18 |
8,015 |
1,443 |
22,878 |
Russell Alan J | Chief Scientific Officer |
Feb 06 '25 |
Option Exercise |
0.18 |
1,200 |
216 |
16,063 |
Russell Alan J | Chief Scientific Officer |
Feb 05 '25 |
Sale |
30.02 |
8,015 |
240,623 |
14,863 |
Russell Alan J | Chief Scientific Officer |
Feb 06 '25 |
Sale |
30.13 |
1,200 |
36,153 |
14,863 |
KOCH KEVIN | President and CEO |
Feb 06 '25 |
Option Exercise |
13.11 |
900 |
11,799 |
15,378 |
자본화:
|
볼륨(24시간):